AARP, Consumers Union back limits on N.Y. drug marketing

May 7, 2007

AARP and Consumers Union are backing two N.Y. bills that would impose limitations on drug marketing and lobbying.

AARP, Consumers Union back limits on N.Y. drug marketingAARP and Consumers Union are backing two N.Y. bills that would impose limitations on drug marketing and lobbying. One bill would require drug companies to disclose to the New York State Department of Health gifts of $75 or more to healthcare practitioners who prescribe drugs. The second bill would prohibit the sale of physician prescription records when the records will be used to market Rx drugs to prescribers. A similar bill in New Hampshire was recently struck down by a U.S. District Court Judge. According to Selig Corman, R.Ph., consultant pharmacist for professional affairs for the Pharmacists Society of the State of New York, the group has not developed a position on either bill and does not expect the bills to have a direct impact on pharmacies. Officials from the Chain Pharmacy Association of New York State could not be reached for comment.

 

To see more Hot off the Press news articles, click here.

To go to the Drug Topics homepage, click here.